Named on one round in the feed.
Since 2020-03-17
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $45M | 2020-03-17 | [ PART ] |